Abstract
Data on endothelial signaling molecules involved in homeostasis regulation and development of age-associated disorders are summarized. Regulation of the endothelium function is implemented by a system of signaling molecules: NO, NO synthase, prostacyclin, thrombomodulin, thromboxane, antithrombin, endothelins, fibronectin, von Willebrand factor, etc. Changes in their synthesis can cause arterial hypertension, atherosclerosis, ischemic heart disease, myocardial infarction, and other age-related disorders. Study of the molecular mechanisms mediating endothelial functioning is essential for developing new methods of diagnostics and a treatment for age-associated cardiovascular diseases.
Similar content being viewed by others
References
Belousov, Yu.B. and Namsaraev, Zh.N., Endothelial dysfunction as a reason of atherosclerotic lesions of arteries in hypertension: the methods of correction, Farmateka, 2009, no. 6(84), pp. 62–72.
Biletskii, S.V., Endothelial dysfunction and pathology of cardiovascular system, Vnutr. Med., 2008, vol. 2, no. 8, pp. 134–139.
Gurevich, M.A. and Sturov, N.V., Deficiency of nitric oxide and maintenance of vascular homeostasis: role of mononitrates and problems of cytoprotection, Trudnyi Patsient, 2010, no. 3, pp. 23–29.
Markov, Kh.M., Nitric oxide and atherosclerosis: nitric oxide, vascular endothelial dysfunction and the pathogenesis of atherosclerosis, Kardiologiya, 2009, no. 11, pp. 64–74.
Smirnova, O.I., Markers of endothelial damage as a possible criterion of the effectiveness of treatment of arterial hypertension, Klin. Lab. Diagnostika, 2007, no. 2, pp. 40–42.
Sozykin, A.V., Noeva, E.A., Balakhonova, T.V., et al., Effect of L-arginine on platelet aggregation, endothelial function, and tolerance to the physical activity in patients with stable exertional angina, Ter. Arkh., 2008, no. 72(8), pp. 24–27.
Fesenko, E.V., Proshchaev, K.I., and Polyakov, V.I., Pleiotropic effects of statin therapy and their role in overcoming polymorbidity, Sovr. Probl. Nauki Obraz., 2012, no. 2, pp. 245–251.
Shevchenko, Yu.L., Stoiko, Yu.M., Gudymovich, V.G., et al., Endothelial dysfunction in patients with varicose veins of the lower extremities and the possibility of its correction, Angiol. Sosudistoi Khir., 2010, vol. 16, no. 4, pp. 137–142.
Alessi, M.C. and Juhan-Vague, I., Contribution of PAI-1 in cardiovascular pathology, Arch. Mal. Coeur Vaiss., 2004, vol. 97, no. 6, pp. 673–678.
Alfieri, A., Ong, A.C., Kammerer, R.A., et al., Angiopoietin-1 regulates microvascular reactivity and protects the microcirculation during acute endothelial dysfunction: role of eNOS and VE-cadherin, Pharmacol. Res. Commun., 2014, vol. 80, pp. 43–51.
Almudéver, P., Milara, J., De Diego, A., et al., Role of tetrahydrobiopterin in pulmonary vascular remodeling associated with pulmonary fibrosis, Thorax, 2013, vol. 68, no. 10, pp. 938–948.
Baylis, C., Nitric oxide deficiency in chronic kidney disease, J. Physiol. Renal Physiol., 2008, vol. 294, pp. 1–9.
Brunini, T.M., Moss, M.B., Siqueira, M.A., et al., Nitric oxide, malnutrition and chronic renal failure, Cardiovasc. Hematol. Agents Med. Chem., 2007, vol. 5, no. 2, pp. 155–161.
Brunner, H., Cockroft, J.R., Deanfield, J., et al., Endothelial function and dysfunction. Part II, J. Hypertens., 2005, vol. 23, pp. 233–246.
Bryan, N.S. and Bian, K.F., Discovery of the nitric oxide signaling pathway and targets for drug development, Front. Biosci., 2009, vol. 14, pp. 1–18.
Chao, T.H., Tsai, W.C., Chen, J.Y., et al., Soluble thrombomodulin is a paracrine anti-apoptotic factor for vascular endothelial protection, Int. J. Cardiol., 2014, pp. S0167–0175.
Chen, W., Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition, Am. J. Physiol.: Lung Cell. Mol. Physiol., 2008, vol. 295, pp. L575–L583.
Choi, Y.J., Kim, H.S., Lee, J., et al., Down-regulation of oxidative stress and COX-2 and iNOS expressions by dimethyl lithospermate in aged rat kidney, Arch. Pharm. Res., 2014, vol. 134, pp. 1478–1485.
Doroshenko, B.H., Saliuta, M., Nazar, P.S., et al., State of physiological anticoagulant heparin, antithrombin III and their correction with medicines in patients with acute viral myocarditis, Lik Sprava., 2008, nos. 7–8, pp. 31–34.
Dzugkoev, S.G., Metel’skaya, V.A., and Dzugkoeva, F.S., Effects of endogenous regulators of endothelial NOsynthase on nitric oxide homeostasis and blood serum lipoproteins during experimental diabetes mellitus, Bull. Exp. Biol. Med., 2013, vol. 156, no. 2, pp. 205–208.
Ebong, E.E., Lopez-Quintero, S.V., Rizzo, V., et al., Shear-induced endothelial NOS activation and remodeling via heparin sulfate, glypican-1, and syndecan-1, Integr. Biol., 2014, vol. 434, pp. 1345–1352.
Fang, H., Chen, W., Gao, Y., et al., Molecular mechanisms associated with angiotensin-converting enzymeinhibitory peptide activity on vascular extracellular matrix remodeling, Cardiology, 2014, vol. 127, no. 4, pp. 247–255.
Green, D.J., Jones, H., Thijssen, D., et al., Flowmediated dilation and cardiovascular event prediction: does nitric oxide matter, Hypertension, 2011, vol. 57, pp. 363–369.
Guidelines of cardiovascular disease prevention in clinical practice. Joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice, Eur. Heart J., 2007, vol. 28, pp. 2375–2414.
Gyongyosi, M., Glogar, D., Weidinger, F., et al., Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-ST-segment elevation myocardial infarction, Am. Heart J., 2004, vol. 147, no. 1, pp. 158–164.
Horinouchi, T., Terada, K., Higashi, T., and Miwa, S., Endothelin receptor signaling: new insight into its regulatory mechanisms, J. Pharmacol. Sci., 2013, vol. 123, no. 2, pp. 85–101.
Iba, T., Miki, T., Hashiguchi, N., et al., Combination of antithrombin and recombinant thrombomodulin attenuates leukocyteendothelial interaction and suppresses the increase of intrinsic damage-associated molecular patterns in endotoxemic rats, J. Surg. Res., 2013, pp. S0022–0031.
Irani, S., Salajegheh, A., Smith, R.A., and Lam, A.K., A review of the profile of endothelin axis in cancer and its management, Crit. Rev. Oncol. Hematol., 2014, vol. 89, no. 2, pp. 314–321.
Isakadze, A., Burkadze, N., and Noniashvili, M., The importance of risk factors in emergence and development of ischemic heart disease, Georgian Med. News, 2011, vol. 11, no. 200, pp. 56–59.
Jiang, D.M., Han, J., Zhu, J.H., et al., Paracrine effects of bone marrow-derived endothelial progenitor cells: cyclooxygenase-2/prostacycli pathway in pulmonary arterial hypertension, PLoS One, 2013, vol. 18, no. 8(11), pp. 79215–79220.
Kohan, D.E., Role of collecting duct endothelin in control of renal function and blood pressure, Am. J. Physiol.: Regul., Integr. Comp. Physiol., 2013, vol. 305, no. 7, pp. R659–R668.
Kolettis, T.M., Ventricular tachyarrhythmias during acute myocardial infarction: the role of endothelin-1, Life Sci., 2014, pp. 2321–2329.
Lundgren, C.H., Sawa, H., Sobel, B.E., and Fuji, S., Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy, Circulation, 1994, vol. 90, pp. 1927–1934.
Maurin, N., The role of platelets in atherosclerosis, diabetes mellitus, and chronic kidney disease. An attempt at explaining the treat study results, Med. Klin., 2010, vol. 105, no. 5, pp. 339–344.
Mayer, B., Translocation of endothelial nitric oxide synthase: another feat of amlodipine, a cardiovascular jack-of-all-trades, Cardiovasc. Res., 2006, vol. 71, pp. 411–413.
Meng, W., Zhao, W., Zhao, T., et al., Autocrine and paracrine function of angiotensin 1–7 in tissue repair during hypertension, Am. J. Hypertens., 2014, vol. 112, pp. 1321–1328.
Montoro-García, S., Shantsila, E., and Lip, G.Y., Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease, Exp. Opin. Ther. Targets, 2014, vol. 18, no. 1, pp. 43–53.
Nyberg, M., Seidelin, K., and Rostgaard, A.T., Biomarkers of vascular function in preand recent postmenopausal women of similar age: effect of exercise training, Am. J. Physiol.: Regul., Integr. Comp. Physiol., 2014, vol. 112, pp. 1355–1361.
Oka, R.K., Szuba, A., Giacomini, J.C., and Cooke, J.P., A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease, Vasc. Med., 2005, vol. 10, no. 4, pp. 265–274.
Peshavariya, H.M., Liu, G.S., Chang, C.W., et al., Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis, Antioxid. Redox Signaling, 2014, vol. 121, pp. 1568–1574.
Saddadi, F., Alatab, S., Pasha, F., et al., The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein andinterleukin-6 in patients on hemodialysis, Saudi J. Kidney Dis. Transplantol., 2014, vol. 25, no. 1, pp. 66–72.
Shanahan, L., Freeman, J., and Bauldry, S., Is very high C-reactive protein in young adults associated with indicators of chronic disease risk?, Psychoneuroendocrinology, 2014, vol. 40, pp. 76–85.
Shawn, S., Badal, R., Farhad, R., and Danesh, J., Strategies to reverse endothelial dysfunction in diabetic nephropathy, Kidney Int., 2012, vol. 82, no. 11, pp. 1151–1154.
Senchenkova, E.Y., Russell, J., Esmon, C.T., and Granger, D.N., Roles of coagulation and fibrinolysis in angiotensin IIenhanced microvascular thrombosis, Microcirculation, 2014, vol. 335, pp. 1890–1897.
Skoglund, P.H., Arpegard, J., Ostergren, J., and Svensson, P., Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure, Amer. J. Hypertens., 2014, vol. 27, no. 3, pp. 363–371.
Tang, L., Wang, H., and Ziolo, M.T., Targeting NOS as a therapeutic approach for heart failure, Pharmacol. Ther., 2013, pp. S0163–7258.
Versari, D., Daghini, E., Virdis, A., et al., Endothelial dysfunction as a target for prevention of cardiovascular disease, Diabetes Care, 2009, vol. 32, pp. 314–321.
Yammine, L., Kang, D.H., Baun, M.M., and Meininger, J.C., Endothelin-1 and psychosocial risk factors for cardiovascular disease: a systematic review, Psychosom. Med., 2014, vol. 76, no. 2, pp. 109–121.
Zurek, P., Debin-ski, M., Czerwinski, W., et al., Acute myocardial infarction with simultaneous occlusions of two coronary arteries in a 44 year-old man, Kardiol. Pol., 2013, vol. 71, no. 3, pp. 279–282.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © K.L. Kozlov, V.M. Soldatov, E.M. Paltseva, E.V. Sedov, V.O. Polyakova, N.S. Linkova, 2015, published in Uspekhi Gerontologii, 2015, Vol. 28, No. 1, pp. 29–36.
Rights and permissions
About this article
Cite this article
Kozlov, K.L., Soldatov, V.M., Paltseva, E.M. et al. Endothelial signaling molecules in the development of age-associated diseases. Adv Gerontol 5, 121–127 (2015). https://doi.org/10.1134/S2079057015020071
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079057015020071